From TradingView · · 2m
Cooper Companies Faces Strategic Shift After Earnings Plunge
Cooper Companies stock drops 26% after management cuts 2026 guidance and retains CooperSurgical unit.
In brief
Cooper Companies stock drops 26% after management cuts 2026 guidance and retains CooperSurgical unit. Cooper Companies stock fell 26% following a post-earnings plunge after management cut full-year 2026 revenue guidance and decided to keep CooperSurgical instead of selling it. Originally reported by TradingView.
Cooper Companies Earnings Plunge
Cooper Companies stock dropped 26% after management cut full-year 2026 revenue guidance and decided to retain CooperSurgical instead of selling it.
“Cooper Companies. Hurst's cycles suggests adding it 2 watch list for NASDAQ:COO”
Hurst Cycles Technical Analysis
Hurst cycles suggest Cooper Companies stock may be near a price trough with potential for a sharp rebound.
“Hurst Cycles are a technical analysis framework developed in the 1970s by aerospace engineer and market researcher J.M. Hurst”
Bullish Case for Cooper
Cooper Companies anticipates $2 billion in free cash flow over three years to fund a $3 billion share buyback program.
“The Bullish Case • Inflection in Free Cash Flow: A multi-year capital expenditure cycle, primarily driven by expanding internal capacity for premium MyDAY contact lenses, is finally winding down”
Bearish Case for Cooper
Cooper Companies faces slowing core momentum with revenue missing expectations and guidance cuts.
“The Bearish Case • Slowing Core Momentum & Guidance Cuts: Third-quarter revenue of $1.066 billion missed expectations”
CooperSurgical Valuation Overhang
CooperSurgical faces structural pressures including soft capital equipment sales and flat performance from non-hormonal IUDs.
“The CooperSurgical Valuation Overhang: Deciding to retain CooperSurgical dismantled a massive catalyst for an immediate unlock of shareholder value”
Jana Partners Campaign
Jana Partners holds 1.8% stake and has threatened a proxy fight to replace CEO and force asset sales.
“JANA Partners is deeply embedded in COO, holding an approximate 1.8% stake (3.58 million shares)”
Director Stock Purchases
Three directors bought $1.8 million worth of Cooper Companies stock immediately after earnings guidance cut.
“Lawrence Erik Kurzius (Director): September 16, 2026: Purchased 10,000 shares at $54.93 per share (Value: $549,320)”
Market Reaction
Institutional investors show mixed signals with 416 funds adding positions versus 268 funds removing positions.
“Over the most recent rolling tracking cycle, 416 active mutual funds and institutional managers function as buyers”
CooperSurgical Strategic Shift
CooperSurgical faces market share erosion and declining capital equipment sales due to competitive pressures.
“Fresh competitive entrants into the non-hormonal long-acting reversible contraceptive (LARC) market are breaking Paragard's monopoly”
Elliott Wave Analysis
Elliott wave analysis shows potential for a price reversal but requires confirmation of wave completion.
“In Elliott wave counts we do not confirm until it's well established and finished = This count is not valid until it's proven after the fact”
Cooper Companies Fundamentals
Cooper Companies stock trades at 12.6x forward earnings with activist support for leadership refresh.
“At roughly 12.6x forward earnings, the stock sits well below its historical premium multiples”
Strategic Implications
Cooper Companies' long-term financial modeling shifts from steady growth to margin recovery and share repurchases.
“These factors will directly alter its long-term financial modeling for the 2027, 2030 time horizon”
Market Sentiment
Cooper Companies stock has fallen 29% since closing at $76.73 on August 19, 2026.
“Barron's chose Cooper Cos. a stock pick on Aug. 7. Shares have declined 26% since then as of the closing bell on Thursday”
CooperSurgical Market Position
CooperSurgical faces declining market share and structural pressures from competitive entrants.
“The primary headwind facing the CooperVision division is severe channel inventory destocking in the U.S.”
Next Steps
Cooper Companies faces potential leadership changes and strategic realignment following activist pressure.
“JANA has explicitly threatened a full-scale proxy fight ahead of the upcoming January nomination deadline if management refuses to cooperate”
At a glance
Cooper Companies stock fell 26% following a post-earnings plunge after management cut full-year 2026 revenue guidance and decided to keep CooperSurgical instead of selling it.
